References
- Mikhail GR. Cancers, precancers, and pseudocancers on the male genitalia. A review of clinical appearances, histopathology, and management. J Dermatol Surg Oncol. 1980;6:1027–1035.
- Henquet CJM. Anogenital malignancies and pre-malignancies. J Eur Acad Dermatol Venereol 2011; 2011 Jan 28. doi: 10.1111/j.1468-3083.2010.03969.x. [Epub ahead of print].
- Stables GI, Stringer MI, Robinson DJ, Ash DV. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol. 1999;140:514–517.
- Varma S, Holt PJA, Anstey AV. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy: a cautionary tale. Br J Dermatol. 2000;142:825–826.
- Lee MR, Ryman W. Erythroplasia of Queyrat treated with topical methyl aminolevulinate photodynamic therapy. Australas J Dermatol. 2005;46:196–198.
- Wang XL, Wang HW, Guo MX, Xu SZ. Treatment of skin cancer and pre-cancer using topical ALA-PDT–a single hospital experience. Photodiagnosis Photodyn Ther. 2008;5:127–133.
- Foley P. Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy. J Dermatolog Treat. 2003;14:(Suppl 3)15–22.
- Allison RR, Sibata CH. Photodynamic therapy: mechanism of action and role in the treatment of skin disease. G Ital Dermatol Venereol. 2010;145:491–507.
- Ortel B, Calzavara-Pinton P. Advances in photodynamic therapy. A review. G Ital Dermatol Venereol. 2010;145:461–475.
- Stebbins WG, Hanke CW. MAL-PDT for difficult to treat nonmelanoma skin cancer. Dermatol Ther. 2011;24:82–93.